Rituximab for the treatment of corticosteroid-refractory pemphigus vulgaris with oral and skin manifestations. [electronic resource]
Producer: 20120207Description: 616-20 p. digitalISSN:- 1600-0714
- Adjuvants, Immunologic -- therapeutic use
- Adrenal Cortex Hormones -- therapeutic use
- Aged
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antigens, CD20
- Drug Administration Schedule
- Drug Resistance
- Female
- Follow-Up Studies
- Humans
- Immunologic Factors -- administration & dosage
- Immunosuppressive Agents -- therapeutic use
- Male
- Middle Aged
- Mouth Diseases -- complications
- Pemphigus -- complications
- Rituximab
- Severity of Illness Index
- Skin Diseases -- complications
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.